HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Authors

Mansi R. Shah, MD
Recent : Trials Examining Cilta-Cel in Relapsed/Refractory Multiple Myeloma: Mansi R. Shah, MD
Kelly Garvin, BSN, RN
Recent : CAR T Therapy in Non-Hodgkin Lymphoma: Kelly Garvin, BSN, RN
Javier L. Munoz, MD, MS, FACP
Recent : CAR T and Other Options for Relapsed/Refractory Follicular Lymphoma: Javier L. Munoz, MD, MS, FACP

Director, Lymphoma Program, Mayo Clinic

Yazeed Sawalha, MD
Recent : ASCT Utilization Rates in Mantle Cell Lymphoma: Yazeed Sawalha, MD
Michael Singer, MD, PhD
Recent : Combining RNA and CAR T-Cell Therapy for Myasthenia Gravis

Chief Scientific Officer, Cartesian Therapeutics

Adham Bear, MD
Recent : Adham Bear, MD, On Immunotherapy Targeting Mutant KRAS
Brian Culley
Recent : Cell Therapy for Dry AMD and Beyond: Next Steps

Brian Culley is chief executive officer of Lineage Cell Therapeutics.

Joshua Richter, MD
Recent : Looking Forward in Relapsed/Refractory Multiple Myeloma Treatments

Assistant professor of medicine, hematology and medical oncology at Mount Sinai.

Karen Pignet-Aiach
Recent : Developing Gene Therapies for Indications With Unmet Needs

Founder, chair, and chief executive officer, Lysogene

Michael Leek, PhD
Recent : Michael Leek, PhD, on Manufacturing Challenges in Cell Therapy